Sector portfolio · Investor · United States
Gates Foundation's Biotech portfolio
Gates Foundation has backed 18 Biotech startups in rounds we track, $2.6B between them, shown by the stage each has reached. The best-funded is Curevac.
Gates Foundation's whole portfolioGates Foundation's profile
Funding by segment
- Series C and later$2.0B11
- Series A$126M3
- Stage not reported$442M2
- Series B$88M2
Where they are based
- United States12$1.7B
- United Kingdom2$382M
- Germany1$358M
- Belgium1$77M
- China1$64M
- Australia1$24M
United States
United Kingdom
Germany
Belgium
China
AustraliaFounded
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M2
- $50M to $250M13
- $250M to $1B3
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
15 of 18 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States12
- United Kingdom2
- Germany1
- Belgium1
- China1
- Australia1
Startups by country, 6 countries in all.
Segment by segment
Series C and later
11 startups · $2.0B raised
CureVacCureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.Germany$358M- AAtrecaAtreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.United States$313M
ButterflyButterfly is a social media app designed for students, fostering community unity through features such as events, and society integrations.United States$253M- KKymabUnited Kingdom$229M
Lyndra TherapeuticsLyndra Therapeutics is a clinical-stage biopharmaceutical company based in Watertown, Massachusetts.United States$156M
Owlstone MedicalOwlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.United Kingdom$153M
Vedanta BiosciencesVedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.United States$143M
Evolve BioSystemsEvolve Biosystems provides microbiome-based products.United States$124M
Series A
3 startups · $126M raised
Kanvas BiosciencesKanvas Biosciences is a biotechnology company based in Princeton, New Jersey, founded in 2020.United States$61M
SynlogicSynlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.United States$55M- BBoragenUnited States$10M
Stage not reported
2 startups · $442M raised
SomaLogicSomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.United States$247M
SchrödingerSchrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotecUnited States$195M
Series B
2 startups · $88M raised
- JBJust BiotherapeuticsChina$64M
ENA RespiratoryEna Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.Australia$24M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Gates Foundation as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Gates Foundation?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.